Electra Therapeutics Inc. (ETRA) vs Oculis Holding AG (OCS)

Electra Therapeutics Inc. ETRA 7.87 −2.48%
Oculis Holding AG OCS 7.26 −4.85%

Electra Therapeutics Inc. and Oculis Holding AG are both Biotechnology companies. Electra Therapeutics Inc. and Oculis Holding AG are of similar size ($506.5M and $471.0M).

Metric	ETRA	OCS	Biotechnology median
P/E	—	n/m	10.64
P/S	—	317.88	9.59
P/B	—	1.69	2.15
Price to free cash flow	—	n/m	26.07
EV/EBITDA	—	n/m	0.65
EV/Sales	—	123.48	9.45
Earnings yield	—	(23.26%)	(34.69%)
Free cash flow yield	—	(17.66%)	(24.02%)

Metric	ETRA	OCS	Biotechnology median
Gross margin	—	100.00%	65.59%
Operating margin	—	(7,383.66%)	0.00%
Net margin	—	(6,870.05%)	0.00%
Free cash flow margin	—	(5,525.64%)	0.00%
Return on equity	—	(44.87%)	(51.96%)
Return on assets	—	(37.69%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ETRA	OCS	Biotechnology median
Revenue growth (TTM)	—	65.83%	4.59%
EPS growth (last fiscal year)	—	5.39%	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	—	—	0.00%

Metric	ETRA	OCS	Biotechnology median
Debt to equity	—	0.01	0.00
Current ratio	—	8.35	4.86
Net debt to EBITDA	—	2.60	1.01

Metric	ETRA	OCS	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	ETRA	OCS	Biotechnology median
Market cap	506.53m	471.01m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack